Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain ...Middle East

MUMBAI, India and TEL AVIV, Israel, Sept. 6, 2024 /PRNewswire/ -- Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Limited, and includes its subsidiaries or associate companies) and Israel-based Moebius Medical Limited announced...

Hence then, the article about sun pharma and moebius medical announce fast track designation granted for mm ii for the treatment of osteoarthritis knee pain was published today ( Friday 06/09/2024 - 09:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain )

Also on site :

• Brandon Sanderson’s Literary Fantasy Universe ‘Cosmere’ Picked Up by Apple TV (Exclusive)
• Merz rejects Zelensky’s ‘concrete date’ for EU membership
• Driver ‘intentionally’ rams car into synagogue in New York (VIDEO)